Ikeda R, Kimura C, Nihashi Y, Umezawa K, Shimosato T, Takaya T
Life (Basel). 2025; 14(12.
PMID: 39768281
PMC: 11679607.
DOI: 10.3390/life14121572.
Yang C, Leifer C, Lammerding J, Hu F
J Biol Chem. 2024; 300(12):107999.
PMID: 39551138
PMC: 11719319.
DOI: 10.1016/j.jbc.2024.107999.
Hopfinger A, Schmid A, Schweitzer L, Patz M, Weber A, Schaffler A
Int J Mol Sci. 2023; 24(21).
PMID: 37958808
PMC: 10649744.
DOI: 10.3390/ijms242115820.
Wiest M, Gu C, Ham H, Gorvel L, Keddis M, Griffing L
Front Immunol. 2023; 14:1144127.
PMID: 37020542
PMC: 10067882.
DOI: 10.3389/fimmu.2023.1144127.
Liu L, Wang Y, Wang W, Ying W, Sun B, Wang X
Front Pediatr. 2023; 10:1091571.
PMID: 36619523
PMC: 9811674.
DOI: 10.3389/fped.2022.1091571.
Activation of CpG-ODN-Induced TLR9 Signaling Inhibited by Interleukin-37 in U937 Human Macrophages.
Kim S, Choe J, Park K
Yonsei Med J. 2021; 62(11):1023-1031.
PMID: 34672136
PMC: 8542467.
DOI: 10.3349/ymj.2021.62.11.1023.
A Cationic Metal-Organic Framework to Scavenge Cell-Free DNA for Severe Sepsis Management.
Liu F, Sheng S, Shao D, Xiao Y, Zhong Y, Zhou J
Nano Lett. 2021; 21(6):2461-2469.
PMID: 33686851
PMC: 8320336.
DOI: 10.1021/acs.nanolett.0c04759.
-Formylated Peptide Induces Increased Expression of Both Formyl Peptide Receptor 2 (Fpr2) and Toll-Like Receptor 9 (TLR9) in Schwannoma Cells-An In Vitro Model for Early Inflammatory Profiling of Schwann Cells.
Korimova A, Dubovy P
Cells. 2020; 9(12).
PMID: 33322305
PMC: 7763069.
DOI: 10.3390/cells9122661.
Toll-like receptor-mediated innate immunity against herpesviridae infection: a current perspective on viral infection signaling pathways.
Zheng W, Xu Q, Zhang Y, E X, Gao W, Zhang M
Virol J. 2020; 17(1):192.
PMID: 33298111
PMC: 7726878.
DOI: 10.1186/s12985-020-01463-2.
The effect of anesthetics on toll like receptor 9.
Koutsogiannaki S, Bu W, Hou L, Shibamura-Fujiogi M, Ishida H, Ohto U
FASEB J. 2020; 34(11):14645-14654.
PMID: 32901993
PMC: 7814252.
DOI: 10.1096/fj.202000791RR.
A non-viral genome editing platform for site-specific insertion of large transgenes.
Chaudhari N, Rickard A, Roy S, Droge P, Makhija H
Stem Cell Res Ther. 2020; 11(1):380.
PMID: 32883366
PMC: 7650303.
DOI: 10.1186/s13287-020-01890-6.
Endosomal Organization of CpG Constructs Correlates with Enhanced Immune Activation.
Lee K, Huang Z, Mirkin C, Odom T
Nano Lett. 2020; 20(8):6170-6175.
PMID: 32787186
PMC: 7609249.
DOI: 10.1021/acs.nanolett.0c02536.
Combined TLR4 and TLR9 agonists induce distinct phenotypic changes in innate immunity in vitro and in vivo.
Lampe A, Puniya B, Pannier A, Helikar T, Brown D
Cell Immunol. 2020; 355:104149.
PMID: 32619809
PMC: 7477748.
DOI: 10.1016/j.cellimm.2020.104149.
HSV-1/TLR9-Mediated IFNβ and TNFα Induction Is Mal-Dependent in Macrophages.
Zyzak J, Mitkiewicz M, Leszczynska E, Reniewicz P, Moynagh P, Siednienko J
J Innate Immun. 2019; 12(5):387-398.
PMID: 31851971
PMC: 7506264.
DOI: 10.1159/000504542.
CD93 is a cell surface lectin receptor involved in the control of the inflammatory response stimulated by exogenous DNA.
Nativel B, Ramin-Mangata S, Mevizou R, Figuester A, Andries J, Iwema T
Immunology. 2019; 158(2):85-93.
PMID: 31335975
PMC: 6742780.
DOI: 10.1111/imm.13100.
Bacterial TLR4 and NOD2 signaling linked to reduced mitochondrial energy function in active inflammatory bowel disease.
Ruiz E, Penrose H, Heller S, Nakhoul H, Baddoo M, Flemington E
Gut Microbes. 2019; 11(3):350-363.
PMID: 31063017
PMC: 7524318.
DOI: 10.1080/19490976.2019.1611152.
Mitochondrial Damage-Associated Molecular Patterns of Injured Axons Induce Outgrowth of Schwann Cell Processes.
Korimova A, Klusakova I, Hradilova-Svizenska I, Kohoutkova M, Joukal M, Dubovy P
Front Cell Neurosci. 2018; 12:457.
PMID: 30542268
PMC: 6277938.
DOI: 10.3389/fncel.2018.00457.
DAMP-Inducing Adjuvant and PAMP Adjuvants Parallelly Enhance Protective Type-2 and Type-1 Immune Responses to Influenza Split Vaccination.
Hayashi T, Momota M, Kuroda E, Kusakabe T, Kobari S, Makisaka K
Front Immunol. 2018; 9:2619.
PMID: 30515151
PMC: 6255964.
DOI: 10.3389/fimmu.2018.02619.
Smaller CpG-Conjugated Gold Nanoconstructs Achieve Higher Targeting Specificity of Immune Activation.
Yue J, Pallares R, Cole L, Coughlin E, Mirkin C, Lee A
ACS Appl Mater Interfaces. 2018; 10(26):21920-21926.
PMID: 29873227
PMC: 6101240.
DOI: 10.1021/acsami.8b06633.
Vaccine Adjuvant Incorporation Strategy Dictates Peptide Amphiphile Micelle Immunostimulatory Capacity.
Zhang R, Kramer J, Smith J, Allen B, Leeper C, Li X
AAPS J. 2018; 20(4):73.
PMID: 29858738
DOI: 10.1208/s12248-018-0233-6.